Polyethylene glycol (PEG) in mRNA-based COVID-19 vaccines: Impact, immunogenicity, and its potential role in post-vaccination induced hypersensitivity. - Egyptian Knowledge Bank - troweb

290713

Polyethylene glycol (PEG) in mRNA-based COVID-19 vaccines: Impact, immunogenicity, and its potential role in post-vaccination induced hypersensitivity.

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Complement activation-related pseudo allergy of PEGylated products: Safety aspects, models, the role of anti-PEG antibodies, and ways to overcome

Article

Immune Responses to PEGylated lipoplexes, a review

Article

Polyethylene glycol: Properties, applications, and challenges

Article

Immunogenicity of Vaccine Encoding Spike Protein against Middle East Respiratory Syndrome Coronavirus in Mammalian Model

Article

Emerging Trends in mRNA Vaccine Technology: Beyond Infectious Diseases

Article

Liposomes and PEGylated liposomes as drug delivery system

Article

Effect of PEG on Structure and Physical Properties of PVA/CMC Nanofiber

Article

Biochemical Study for The Effect of Pfizer‐BioNTech COVID‐19 Vaccine

Article

Global acceptance and rejection of COVID-19 vaccines: A systematic review and meta-analysis

Article

INHIBITION EFFECT OF SOME POLYETHYLENE GLYCOLS (PEG) ON THE CORROSION OF ALUMINUM IN 1.0 M PHOSPHORIC ACID